Medical News

RSS

ACC designates USF Health CAMLS as first Center of Excellence in Education and Training

The American College of Cardiology has designated the USF Health Center of Advanced Learning and Simulation (CAMLS) as its first Center of Excellence in Education and Training.

10 Apr 2012

Study: Body and head lice are the same species

A new study offers compelling genetic evidence that head and body lice are the same species. The finding is of special interest because body lice can transmit deadly bacterial diseases, while head lice do not.

10 Apr 2012

FDA grants Fast Track designation to EpiCept's AmiKet

EpiCept Corporation announced today that AmiKet (amitriptyline 4%, ketamine 2% cream) has been granted Fast Track designation by the U.S. Food and Drug Administration.

10 Apr 2012

Regular dental x-rays increase risk of meningioma in the U.S.

People who received frequent dental x-rays in the past have an increased risk of developing the most commonly diagnosed primary brain tumor in the United States. That is the finding of a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society.

10 Apr 2012

FDA approval of OMONTYS triggers $50M milestone payment to Affymax

Affymax, Inc. today announced that it has received a $50 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize OMONTYS (peginesatide) Injection.

10 Apr 2012

Proteonomix provides corporate and clinical trial updates

Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today provided updates on its progress.

10 Apr 2012

Affiliate of Sun Capital acquires CornerStone

Sun Capital Partners, Inc., a leading private investment firm specializing in leveraged buyouts and investments in market-leading companies, today announced that an affiliate has acquired CornerStone Research & Development, Inc., a leading global contract manufacturer of top-branded vitamins and dietary supplements, from Mitsui & Co. (U.S.A.), Inc.

10 Apr 2012

Mayo Clinic introduces Breast Cancer Genome Guided Therapy Study

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

10 Apr 2012

Higher blood glucose levels may improve survival rates for heart failure patients with diabetes

Lowering glucose levels for people with diabetes is normally critical to improving health outcomes. But for those with heart failure, that might not always be the case, say UCLA researchers.

10 Apr 2012

CEO Roundtable on Cancer accredits Allegeant

The CEO Roundtable on Cancer recently accredited health management company Allegeant, LLC, of Baltimore, Maryland with the CEO Cancer Gold Standard recognizing the staffing company's efforts to reduce the risk of cancer for their employees and covered family members by promoting healthy lifestyle choices, encouraging early detection through cancer screenings and ensuring access to quality treatment.

10 Apr 2012

KLF15 gene governs the body's ability to burn fat during exercise

While exercise is accepted universally as the most beneficial prescription physicians can write for patients, little is known about the molecular mechanisms that generate its widespread health benefits. Researchers from Case Western Reserve School of Medicine have shed light on this mystery by discovering that a genetic factor, Kruppel-like Factor 15 (KLF15), governs the body's ability to burn fat during exercise.

10 Apr 2012

Three ESRD products chosen for FDA's Innovation Pathway program

Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA's Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.

10 Apr 2012

UofL wins NIH grant for cardiac clinical research center

During his 18-year tenure at UofL, Dr. Roberto Bolli has generated more than $100 million in grants for basic research from the NIH. Today, Bolli joined with University of Louisville President James R. Ramsey to announce a new NIH grant he has won for clinical research, a seven-year, $3.4 million grant from the National Heart, Lung and Blood Institute to establish one of seven regional centers across the United States in the Cardiac Cell Therapy Research Network.

10 Apr 2012

Flextronics acquires Stellar Microelectronics

Flextronics today announced that it has completed its previously announced acquisition of Stellar Microelectronics.

10 Apr 2012

RegeneRx wins four patents in Israel, Mexico

RegeneRx Biopharmaceuticals, Inc. announced today that the Company has received an issued patent in Mexico and allowances of three additional patent applications in Mexico and Israel.

10 Apr 2012

ReCor Medical provides updated data from REDUCE Percutaneous Renal Denervation System study

ReCor Medical, an emerging medical device company, disclosed today updated data for the REDUCE First-In-Man clinical study of its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation.

10 Apr 2012

Monitoring necessary for early intervention in Fuchs' Endothelial Corneal Dystrophy patients

A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation.

10 Apr 2012

HDS signs LOI with PharmaLife to market Clotamin in Russia

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC are pleased to announce that HDS has signed a Letter of Intent with PharmaLife for placement of Clotamin with leading pharmacies in the Russian Federation.

10 Apr 2012

Preeclampsia Foundation to hold Promise Walks in May

May is Preeclampsia Awareness Month and to build awareness of preeclampsia, a life-threatening disorder of pregnancy and the post-partum period, thousands of families in 36 cities in the U.S. and Canada are participating in Promise Walks.

10 Apr 2012